Single Cell Genotypic and Phenotypic Analysis of Measurable Residual Disease in Acute Myeloid Leukemia

被引：3

作者：

Robinson, Troy ^{[1
,2
]}

Bowman, Robert L. ^{[2
,3
]}

Persaud, Sonali ^{[2
]}

Liu, Ying ^{[4
,5
]}

Gao, Qi ^{[6
]}

Zhang, Jing-Ping ^{[7
]}

Sun, Xiaotian ^{[6
]}

Sciambi, Adam ^{[8
]}

Llanso, Aaron ^{[9
]}

Famulare, Christopher ^{[10
]}

Goldberg, Aaron D. ^{[11
]}

Dogan, Ahmet ^{[6
]}

Roshal, Mikhail ^{[6
]}

Levine, Ross L. ^{[2
,10
,11
,12
]}

Xiao, Wenbin ^{[2
,6
,10
]}

机构：

[1] Gerstner Sloan Kettering Grad Sch Biomed Sci, New York, NY USA

[2] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA

[3] Mem Sloan Kettering Canc Ctr, Ctr Epigenet Res, New York, NY 10021 USA

[4] Mem Sloan Kettering, Hematopathol Serv, Dept Pathol & Lab Med, New York, NY USA

[5] Mem Sloan Kettering, Mol Diagnost Serv, Dept Pathol & Lab Med, New York, NY USA

[6] Mem Sloan Kettering Canc Ctr, Dept Pathol & Lab Med, Hematopathol Serv, New York, NY USA

[7] Mem Sloan Kettering Canc Ctr, Dept Pathol, Hematopathol Serv, New York, NY 10021 USA

[8] Mission Bio Inc, San Francisco, CA USA

[9] Mission Bio, San Francisco, CA USA

[10] Mem Sloan Kettering Canc Ctr, Ctr Hematol Malignancies, New York, NY 10021 USA

[11] Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, New York, NY 10021 USA

[12] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA

来源：

BLOOD | 2022年 / 140卷

关键词：

D O I：

10.1182/blood-2022-166501

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2275 / 2277

页数：3

共 50 条

[1] Single-cell genotypic and phenotypic analysis of measurable residual disease in acute myeloid leukemia
Robinson, Troy M.
Bowman, Robert L.
Persaud, Sonali
Liu, Ying
Neigenfind, Rosemary
Gao, Qi
Zhang, Jingping
Sun, Xiaotian
Miles, Linde A.
Cai, Sheng F.
Sciambi, Adam
Llanso, Aaron
Famulare, Christopher
Goldberg, Aaron
Dogan, Ahmet
Roshal, Mikhail
Levine, Ross L.
Xiao, Wenbin
SCIENCE ADVANCES, 2023, 9 (38)
[2] Single-cell immune landscape of measurable residual disease in acute myeloid leukemia
Mo, Xiaodong
Zhang, Weilong
Fu, Guomei
Chang, Yingjun
Zhang, Xiaohui
Xu, Lanping
Wang, Yu
Yan, Chenhua
Shen, Mengzhu
Wei, Qiuxia
Yan, Changjian
Huang, Xiaojun
SCIENCE CHINA-LIFE SCIENCES, 2024, 67 (11) : 2309 - 2322
[3] Single-cell immune landscape of measurable residual disease in acute myeloid leukemia
Xiaodong Mo
Weilong Zhang
Guomei Fu
Yingjun Chang
Xiaohui Zhang
Lanping Xu
Yu Wang
Chenhua Yan
Mengzhu Shen
Qiuxia Wei
Changjian Yan
Xiaojun Huang
Science China(Life Sciences), 2024, 67 (11) : 2309 - 2322
[4] Evaluating measurable residual disease in acute myeloid leukemia
Ravandi, Farhad
Walter, Roland B.
Freeman, Sylvie D.
BLOOD ADVANCES, 2018, 2 (11) : 1356 - 1366
[5] Clinical Use of Measurable Residual Disease in Acute Myeloid Leukemia
Roug, Anne Stidsholt
Ommen, Hans Beier
CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2019, 20 (04)
[6] Perspective on measurable residual disease testing in acute myeloid leukemia
Walter, Roland B.
LEUKEMIA, 2024, 38 (01) : 10 - 13
[7] Clinical Use of Measurable Residual Disease in Acute Myeloid Leukemia
Anne Stidsholt Roug
Hans Beier Ommen
Current Treatment Options in Oncology, 2019, 20
[8] Clinical Impact of Measurable Residual Disease in Acute Myeloid Leukemia
Azenkot, Tali
Jonas, Brian A.
CANCERS, 2022, 14 (15)
[9] Improved detection of measurable residual disease in acute myeloid leukemia
Zhang, Xuan
Grimes, H. Leighton
SCIENCE ADVANCES, 2023, 9 (38)
[10] Clonal hematopoiesis and measurable residual disease assessment in acute myeloid leukemia
Hasserjian, Robert P.
Steensma, David P.
Graubert, Timothy A.
Ebert, Benjamin L.
BLOOD, 2020, 135 (20) : 1729 - 1738

← 1 2 3 4 5 →